{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:01:30Z","timestamp":1793289690310,"version":"4.5.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Joint Innovation Fund Project of Chengdu University of TCM and Affiliated Hospitals","award":["Grant No. LH202402056"],"award-info":[{"award-number":["Grant No. LH202402056"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11556-9","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T08:16:21Z","timestamp":1777191381000},"page":"8017-8044","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["AI-driven discovery of natural product-derived FAK1 inhibitors for idiopathic pulmonary fibrosis"],"prefix":"10.1007","volume":"30","author":[{"given":"Xing-Yi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Hong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Lan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben-Rong","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,26]]},"reference":[{"issue":"7835","key":"11556_CR1","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","volume":"587","author":"NC Henderson","year":"2020","unstructured":"Henderson NC, Rieder F, Wynn TA (2020) Fibrosis: from mechanisms to medicines. Nature 587(7835):555\u2013566. https:\/\/doi.org\/10.1038\/s41586-020-2938-9","journal-title":"Nature"},{"key":"11556_CR2","doi-asserted-by":"publisher","DOI":"10.1055\/a-2666-7479","author":"SM Fortier","year":"2025","unstructured":"Fortier SM, Redente EF, Peters-Golden M (2025) Reimagining fibrosis research, outcomes, and therapeutics through the lens of resolution. Semin Respir Crit Care Med. https:\/\/doi.org\/10.1055\/a-2666-7479","journal-title":"Semin Respir Crit Care Med"},{"key":"11556_CR3","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0057-2017","author":"LH Lancaster","year":"2017","unstructured":"Lancaster LH, de Andrade JA, Zibrak JD, Padilla ML, Albera C, Nathan SD, Wijsenbeek MS, Stauffer JL, Kirchgaessler KU, Costabel U (2017) Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis. Eur Respir Rev. https:\/\/doi.org\/10.1183\/16000617.0057-2017","journal-title":"Eur Respir Rev"},{"key":"11556_CR4","doi-asserted-by":"publisher","DOI":"10.1177\/20420986251341645","volume":"16","author":"A Provenzani","year":"2025","unstructured":"Provenzani A, Leonardi Vinci D, Alaimo M, Di Maria S, Tuzzolino F, Floridia G, Di Stefano R, Carollo A, Callari A, Polidori P, Vitulo P (2025) Real-world insights into safety, tolerability, and predictive factors of adverse drug reactions in treating idiopathic pulmonary fibrosis with pirfenidone and nintedanib. Ther Adv Drug Saf 16:20420986251341645. https:\/\/doi.org\/10.1177\/20420986251341645","journal-title":"Ther Adv Drug Saf"},{"issue":"Pt A","key":"11556_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116952","volume":"318","author":"YM Zhou","year":"2024","unstructured":"Zhou YM, Dong XR, Xu D, Tang J, Cui YL (2024) Therapeutic potential of traditional Chinese medicine for interstitial lung disease. J Ethnopharmacol 318(Pt A):116952. https:\/\/doi.org\/10.1016\/j.jep.2023.116952","journal-title":"J Ethnopharmacol"},{"key":"11556_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115003","volume":"161","author":"X Wang","year":"2025","unstructured":"Wang X, Wu X, Zhou L, Lin Y, Tang Z, Chen C, Wang B, Lin Y (2025) Demethyleneberberine ameliorates pulmonary fibrosis by inhibiting the NLRP3 inflammasome and the epithelial-mesenchymal transition. Int Immunopharmacol 161:115003. https:\/\/doi.org\/10.1016\/j.intimp.2025.115003","journal-title":"Int Immunopharmacol"},{"key":"11556_CR7","doi-asserted-by":"publisher","first-page":"9453","DOI":"10.2147\/jir.S493171","volume":"17","author":"C Ding","year":"2024","unstructured":"Ding C, Guo Z, Liao Q, Zuo R, He J, Ye Z, Chen W (2024) Network pharmacology and machine learning reveal salidroside\u2019s mechanisms in idiopathic pulmonary fibrosis treatment. J Inflamm Res 17:9453\u20139467. https:\/\/doi.org\/10.2147\/jir.S493171","journal-title":"J Inflamm Res"},{"issue":"1","key":"11556_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-024-09752-7","volume":"51","author":"Z Li","year":"2024","unstructured":"Li Z, Jiao Y, Wu Z, Liu H, Li Y, Cai Y, Wei W, Cao F (2024) The role of quercetin in ameliorating bleomycin-induced pulmonary fibrosis: insights into autophagy and the SIRT1\/AMPK signaling pathway. Mol Biol Rep 51(1):795. https:\/\/doi.org\/10.1007\/s11033-024-09752-7","journal-title":"Mol Biol Rep"},{"key":"11556_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2023.148040","volume":"897","author":"Y Guan","year":"2024","unstructured":"Guan Y, Zhang J, Cai X, Cai Y, Song Z, Huang Y, Qian W, Pan Z, Zhang X (2024) Astragaloside IV inhibits epithelial-mesenchymal transition and pulmonary fibrosis via lncRNA-ATB\/miR-200c\/ZEB1 signaling pathway. Gene 897:148040. https:\/\/doi.org\/10.1016\/j.gene.2023.148040","journal-title":"Gene"},{"key":"11556_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175594","volume":"944","author":"Y Wei","year":"2023","unstructured":"Wei Y, Qi M, Liu C, Li L (2023) Astragalus polysaccharide attenuates bleomycin-induced pulmonary fibrosis by inhibiting TLR4\/ NF-\u03baB signaling pathway and regulating gut microbiota. Eur J Pharmacol 944:175594. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175594","journal-title":"Eur J Pharmacol"},{"key":"11556_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108400","volume":"159","author":"X Chi","year":"2025","unstructured":"Chi X, Chen R, Chen R, Xu Y, Deng Y, Yang X, Pan Z, Xu X, Pan Y, Li Q, Zhou P, Huang W (2025) Discovery and characterization of novel FAK inhibitors for breast cancer therapy via hybrid virtual screening, biological evaluation and molecular dynamics simulations. Bioorg Chem 159:108400. https:\/\/doi.org\/10.1016\/j.bioorg.2025.108400","journal-title":"Bioorg Chem"},{"key":"11556_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117882","volume":"296","author":"C Gan","year":"2025","unstructured":"Gan C, Wei W, Xue T, Xie Y, Yue L, Su X, Yu Y, Liu Z, Ye T (2025) Focal adhesion kinase inhibitors in fibrotic diseases therapy: development and therapeutic potential. Eur J Med Chem 296:117882. https:\/\/doi.org\/10.1016\/j.ejmech.2025.117882","journal-title":"Eur J Med Chem"},{"issue":"6","key":"11556_CR13","doi-asserted-by":"publisher","first-page":"L926","DOI":"10.1152\/ajplung.00121.2016","volume":"312","author":"Q Ding","year":"2017","unstructured":"Ding Q, Subramanian I, Luckhardt TR, Che P, Waghray M, Zhao XK, Bone N, Kurundkar AR, Hecker L, Hu M, Zhou Y, Horowitz JC, Vittal R, Thannickal VJ (2017) Focal adhesion kinase signaling determines the fate of lung epithelial cells in response to TGF-\u03b2. Am J Physiol Lung Cell Mol Physiol 312(6):L926-l935. https:\/\/doi.org\/10.1152\/ajplung.00121.2016","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"11556_CR14","doi-asserted-by":"publisher","first-page":"L722","DOI":"10.1152\/ajplung.00478.2016","volume":"312","author":"AK Wheaton","year":"2017","unstructured":"Wheaton AK, Agarwal M, Jia S, Kim KK (2017) Lung epithelial cell focal adhesion kinase signaling inhibits lung injury and fibrosis. Am J Physiol Lung Cell Mol Physiol 312(5):L722-l730. https:\/\/doi.org\/10.1152\/ajplung.00478.2016","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"11556_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/srep19276","volume":"6","author":"XK Zhao","year":"2016","unstructured":"Zhao XK, Cheng Y, Liang Cheng M, Yu L, Mu M, Li H, Liu Y, Zhang B, Yao Y, Guo H, Wang R, Zhang Q (2016) Focal adhesion kinase regulates fibroblast migration via Integrin beta-1 and plays a central role in fibrosis. Sci Rep 6:19276. https:\/\/doi.org\/10.1038\/srep19276","journal-title":"Sci Rep"},{"issue":"Pt A","key":"11556_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109409","volume":"113","author":"W Yang","year":"2022","unstructured":"Yang W, Pan L, Cheng Y, Wu X, Tang B, Zhu H, Zhang M, Zhang Y (2022) Nintedanib alleviates pulmonary fibrosis in vitro and in vivo by inhibiting the FAK\/ERK\/S100A4 signalling pathway. Int Immunopharmacol 113(Pt A):109409. https:\/\/doi.org\/10.1016\/j.intimp.2022.109409","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"11556_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18112431","volume":"18","author":"A Gim\u00e9nez","year":"2017","unstructured":"Gim\u00e9nez A, Duch P, Puig M, Gabasa M, Xaubet A, Alcaraz J (2017) Dysregulated collagen homeostasis by matrix stiffening and TGF-\u03b21 in fibroblasts from Idiopathic Pulmonary Fibrosis patients: role of FAK\/Akt. Int J Mol Sci 18(11):2431. https:\/\/doi.org\/10.3390\/ijms18112431","journal-title":"Int J Mol Sci"},{"issue":"40","key":"11556_CR18","doi-asserted-by":"publisher","first-page":"26839","DOI":"10.1074\/jbc.M803645200","volume":"283","author":"Q Ding","year":"2008","unstructured":"Ding Q, Gladson CL, Wu H, Hayasaka H, Olman MA (2008) Focal adhesion kinase (FAK)-related non-kinase inhibits myofibroblast differentiation through differential MAPK activation in a FAK-dependent manner. J Biol Chem 283(40):26839\u201326849. https:\/\/doi.org\/10.1074\/jbc.M803645200","journal-title":"J Biol Chem"},{"issue":"15","key":"11556_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158193","volume":"23","author":"WK Yu","year":"2022","unstructured":"Yu WK, Chen WC, Su VY, Shen HC, Wu HH, Chen H, Yang KY (2022) Nintedanib inhibits endothelial mesenchymal transition in Bleomycin-induced pulmonary fibrosis via focal adhesion kinase activity reduction. Int J Mol Sci 23(15):8193. https:\/\/doi.org\/10.3390\/ijms23158193","journal-title":"Int J Mol Sci"},{"issue":"1","key":"11556_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-023-02747-3","volume":"23","author":"X Wu","year":"2023","unstructured":"Wu X, Chen L, Cheng Y, Zhang Y, Yang W, Pan L, Fu C, Zhu H, Zhang M (2023) A selective CB2R agonist (JWH133) protects against pulmonary fibrosis through inhibiting FAK\/ERK\/S100A4 signaling pathways. BMC Pulm Med 23(1):440. https:\/\/doi.org\/10.1186\/s12890-023-02747-3","journal-title":"BMC Pulm Med"},{"issue":"4","key":"11556_CR21","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1165\/rcmb.2012-0277OC","volume":"49","author":"K Kinoshita","year":"2013","unstructured":"Kinoshita K, Aono Y, Azuma M, Kishi J, Takezaki A, Kishi M, Makino H, Okazaki H, Uehara H, Izumi K, Sone S, Nishioka Y (2013) Antifibrotic effects of focal adhesion kinase inhibitor in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Cell Mol Biol 49(4):536\u2013543. https:\/\/doi.org\/10.1165\/rcmb.2012-0277OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"11556_CR22","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1002\/art.33482","volume":"64","author":"D Lagares","year":"2012","unstructured":"Lagares D, Busnadiego O, Garc\u00eda-Fern\u00e1ndez RA, Kapoor M, Liu S, Carter DE, Abraham D, Shi-Wen X, Carreira P, Fontaine BA, Shea BS, Tager AM, Leask A, Lamas S, Rodr\u00edguez-Pascual F (2012) Inhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation. Arthritis Rheum 64(5):1653\u20131664. https:\/\/doi.org\/10.1002\/art.33482","journal-title":"Arthritis Rheum"},{"issue":"6","key":"11556_CR23","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.3892\/etm.2019.8127","volume":"18","author":"P Zhang","year":"2019","unstructured":"Zhang P, Liu J, Zong R (2019) Triptolide protects against TGF-\u03b21-induced pulmonary fibrosis by regulating FAK\/calpain signaling. Exp Ther Med 18(6):4781\u20134789. https:\/\/doi.org\/10.3892\/etm.2019.8127","journal-title":"Exp Ther Med"},{"issue":"9","key":"11556_CR24","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00109-015-1283-1","volume":"93","author":"P Chitra","year":"2015","unstructured":"Chitra P, Saiprasad G, Manikandan R, Sudhandiran G (2015) Berberine inhibits Smad and non-Smad signaling cascades and enhances autophagy against pulmonary fibrosis. J Mol Med (Berl) 93(9):1015\u20131031. https:\/\/doi.org\/10.1007\/s00109-015-1283-1","journal-title":"J Mol Med (Berl)"},{"issue":"3","key":"11556_CR25","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/cvr\/cvt337","volume":"101","author":"JE Son","year":"2014","unstructured":"Son JE, Lee E, Jung SK, Kim JE, Oak MH, Lee KW, Lee HJ (2014) Anthocyanidins, novel FAK inhibitors, attenuate PDGF-BB-induced aortic smooth muscle cell migration and neointima formation. Cardiovasc Res 101(3):503\u2013512. https:\/\/doi.org\/10.1093\/cvr\/cvt337","journal-title":"Cardiovasc Res"},{"key":"11556_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejmech.2012.06.035","volume":"61","author":"M Iwatani","year":"2013","unstructured":"Iwatani M, Iwata H, Okabe A, Skene RJ, Tomita N, Hayashi Y, Aramaki Y, Hosfield DJ, Hori A, Baba A, Miki H (2013) Discovery and characterization of novel allosteric FAK inhibitors. Eur J Med Chem 61:49\u201360. https:\/\/doi.org\/10.1016\/j.ejmech.2012.06.035","journal-title":"Eur J Med Chem"},{"issue":"23","key":"11556_CR27","doi-asserted-by":"publisher","first-page":"14382","DOI":"10.1021\/acs.jmedchem.0c01248","volume":"63","author":"Y Lu","year":"2020","unstructured":"Lu Y, Sun H (2020) Progress in the development of small molecular inhibitors of focal adhesion kinase (FAK). J Med Chem 63(23):14382\u201314403. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01248","journal-title":"J Med Chem"},{"key":"11556_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2026.117716","volume":"246","author":"Y Zhang","year":"2026","unstructured":"Zhang Y, Lu D, Zhang L, Shao Y, Yan Z, Liu Z (2026) Targeting focal adhesion kinase (FAK) in non-small cell lung cancer (NSCLC): molecular mechanisms and combination therapeutic strategies. Biochem Pharmacol 246:117716. https:\/\/doi.org\/10.1016\/j.bcp.2026.117716","journal-title":"Biochem Pharmacol"},{"issue":"14","key":"11556_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2023.167994","volume":"435","author":"S Bittrich","year":"2023","unstructured":"Bittrich S, Bhikadiya C, Bi C, Chao H, Duarte JM, Dutta S, Fayazi M, Henry J, Khokhriakov I, Lowe R, Piehl DW, Segura J, Vallat B, Voigt M, Westbrook JD, Burley SK, Rose Y (2023) RCSB Protein Data Bank: efficient searching and simultaneous access to one million computed structure models alongside the PDB structures enabled by architectural advances. J Mol Biol 435(14):167994. https:\/\/doi.org\/10.1016\/j.jmb.2023.167994","journal-title":"J Mol Biol"},{"key":"11556_CR30","doi-asserted-by":"publisher","unstructured":"UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res 49(D1) D480-d489. https:\/\/doi.org\/10.1093\/nar\/gkaa1100","DOI":"10.1093\/nar\/gkaa1100"},{"issue":"9","key":"11556_CR31","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/pro.5560020916","volume":"2","author":"C Colovos","year":"1993","unstructured":"Colovos C, Yeates TO (1993) Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci 2(9):1511\u20131519. https:\/\/doi.org\/10.1002\/pro.5560020916","journal-title":"Protein Sci"},{"issue":"5016","key":"11556_CR32","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1126\/science.1853201","volume":"253","author":"JU Bowie","year":"1991","unstructured":"Bowie JU, L\u00fcthy R, Eisenberg D (1991) A method to identify protein sequences that fold into a known three-dimensional structure. Science 253(5016):164\u2013170. https:\/\/doi.org\/10.1126\/science.1853201","journal-title":"Science"},{"issue":"4","key":"11556_CR33","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/bf00228148","volume":"8","author":"RA Laskowski","year":"1996","unstructured":"Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM (1996) AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR 8(4):477\u2013486. https:\/\/doi.org\/10.1007\/bf00228148","journal-title":"J Biomol NMR"},{"issue":"D1","key":"11556_CR34","doi-asserted-by":"publisher","first-page":"D562","DOI":"10.1093\/nar\/gkaa895","volume":"49","author":"GK Kanev","year":"2021","unstructured":"Kanev GK, de Graaf C, Westerman BA, de Esch IJP, Kooistra AJ (2021) KLIFS: an overhaul after the first 5 years of supporting kinase research. Nucleic Acids Res 49(D1):D562-d569. https:\/\/doi.org\/10.1093\/nar\/gkaa895","journal-title":"Nucleic Acids Res"},{"issue":"19","key":"11556_CR35","doi-asserted-by":"publisher","first-page":"5401","DOI":"10.1016\/j.bmcl.2013.07.050","volume":"23","author":"U Gr\u00e4dler","year":"2013","unstructured":"Gr\u00e4dler U, Bomke J, Musil D, Dresing V, Lehmann M, H\u00f6lzemann G, Greiner H, Esdar C, Krier M, Heinrich T (2013) Fragment-based discovery of focal adhesion kinase inhibitors. Bioorg Med Chem Lett 23(19):5401\u20135409. https:\/\/doi.org\/10.1016\/j.bmcl.2013.07.050","journal-title":"Bioorg Med Chem Lett"},{"issue":"Web Server issu","key":"11556_CR36","doi-asserted-by":"publisher","first-page":"W537","DOI":"10.1093\/nar\/gks375","volume":"40","author":"R Anandakrishnan","year":"2012","unstructured":"Anandakrishnan R, Aguilar B, Onufriev AV (2012) H++ 3.0: automating pK prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations. Nucleic Acids Res 40(Web Server issue):W537\u2013W541. https:\/\/doi.org\/10.1093\/nar\/gks375","journal-title":"Nucleic Acids Res"},{"issue":"39","key":"11556_CR37","doi-asserted-by":"publisher","first-page":"10684","DOI":"10.1039\/d3sc02139d","volume":"14","author":"Q Lv","year":"2023","unstructured":"Lv Q, Chen G, He H, Yang Z, Zhao L, Chen HY, Chen CY (2023) TCMBank: bridges between the largest herbal medicines, chemical ingredients, target proteins, and associated diseases with intelligence text mining. Chem Sci 14(39):10684\u201310701. https:\/\/doi.org\/10.1039\/d3sc02139d","journal-title":"Chem Sci"},{"issue":"D1","key":"11556_CR38","doi-asserted-by":"publisher","first-page":"D1197","DOI":"10.1093\/nar\/gkaa1063","volume":"49","author":"S Fang","year":"2021","unstructured":"Fang S, Dong L, Liu L, Guo J, Zhao L, Zhang J, Bu D, Liu X, Huo P, Cao W, Dong Q, Wu J, Zeng X, Wu Y, Zhao Y (2021) HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine. Nucleic Acids Res 49(D1):D1197-d1206. https:\/\/doi.org\/10.1093\/nar\/gkaa1063","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"11556_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-025-00637-w","volume":"39","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Mu BR, Chen XY, Liu L, Wu QL, Lu MH, Qiao FL (2025) Integrated machine learning and deep learning-based virtual screening framework identifies novel natural GSK-3\u03b2 inhibitors for Alzheimer\u2019s disease. J Comput Aided Mol Des 39(1):53. https:\/\/doi.org\/10.1007\/s10822-025-00637-w","journal-title":"J Comput Aided Mol Des"},{"issue":"D1","key":"11556_CR40","doi-asserted-by":"publisher","first-page":"D1516","DOI":"10.1093\/nar\/gkae1059","volume":"53","author":"S Kim","year":"2025","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q, Shoemaker BA, Thiessen PA, Yu B, Zaslavsky L, Zhang J, Bolton EE (2025) PubChem 2025 update. Nucleic Acids Res 53(D1):D1516-d1525. https:\/\/doi.org\/10.1093\/nar\/gkae1059","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"11556_CR41","doi-asserted-by":"publisher","first-page":"D1180","DOI":"10.1093\/nar\/gkad1004","volume":"52","author":"B Zdrazil","year":"2024","unstructured":"Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizil\u00f6ren T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR (2024) The ChEMBL database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res 52(D1):D1180-d1192. https:\/\/doi.org\/10.1093\/nar\/gkad1004","journal-title":"Nucleic Acids Res"},{"issue":"19","key":"11556_CR42","doi-asserted-by":"publisher","first-page":"10673","DOI":"10.1021\/acs.jcim.5c01521","volume":"65","author":"L Zhao","year":"2025","unstructured":"Zhao L, Liu H, Yao X, Ma X, Liu B, Li B, Tong HHY, Zhang Q (2025) Integrated machine learning and structure-based virtual screening identify Osimertinib as a TNIK inhibitor for Idiopathic Pulmonary Fibrosis. J Chem Inf Model 65(19):10673\u201310687. https:\/\/doi.org\/10.1021\/acs.jcim.5c01521","journal-title":"J Chem Inf Model"},{"issue":"1","key":"11556_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04443-6","volume":"21","author":"Z Wang","year":"2023","unstructured":"Wang Z, Sun L, Xu Y, Liang P, Xu K, Huang J (2023) Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation. J Transl Med 21(1):579. https:\/\/doi.org\/10.1186\/s12967-023-04443-6","journal-title":"J Transl Med"},{"key":"11556_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107553","volume":"150","author":"Y Wang","year":"2024","unstructured":"Wang Y, Shen Z, Chen R, Chi X, Li W, Xu D, Lu Y, Ding J, Dong X, Zheng X (2024) Discovery and characterization of novel FGFR1 inhibitors in triple-negative breast cancer via hybrid virtual screening and molecular dynamics simulations. Bioorg Chem 150:107553. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107553","journal-title":"Bioorg Chem"},{"issue":"11","key":"11556_CR45","doi-asserted-by":"publisher","DOI":"10.1111\/cts.70056","volume":"17","author":"AV Ponce-Bobadilla","year":"2024","unstructured":"Ponce-Bobadilla AV, Schmitt V, Maier CS, Mensing S, Stodtmann S (2024) Practical guide to SHAP analysis: Explaining supervised machine learning model predictions in drug development. Clin Transl Sci 17(11):e70056. https:\/\/doi.org\/10.1111\/cts.70056","journal-title":"Clin Transl Sci"},{"issue":"Pt 1","key":"11556_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.136325","volume":"282","author":"X Wu","year":"2024","unstructured":"Wu X, Liang J, Meng L, Wang B, Liu B, Jin Y (2024) Towards novel small-molecule inhibitors blocking PD-1\/PD-L1 pathway: From explainable machine learning models to molecular dynamics simulation. Int J Biol Macromol 282(Pt 1):136325. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136325","journal-title":"Int J Biol Macromol"},{"issue":"14","key":"11556_CR47","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1021\/jm300687e","volume":"55","author":"MM Mysinger","year":"2012","unstructured":"Mysinger MM, Carchia M, Irwin JJ, Shoichet BK (2012) Directory of useful decoys, enhanced (DUD-E): Better ligands and decoys for better benchmarking. J Med Chem 55(14):6582\u20136594. https:\/\/doi.org\/10.1021\/jm300687e","journal-title":"J Med Chem"},{"issue":"5","key":"11556_CR48","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","volume":"24","author":"D Seeliger","year":"2010","unstructured":"Seeliger D, de Groot BL (2010) Ligand docking and binding site analysis with PyMOL and Autodock\/Vina. J Comput Aided Mol Des 24(5):417\u2013422. https:\/\/doi.org\/10.1007\/s10822-010-9352-6","journal-title":"J Comput Aided Mol Des"},{"issue":"1","key":"11556_CR49","doi-asserted-by":"publisher","DOI":"10.1088\/1755-1315\/218\/1\/012143","volume":"218","author":"N Liu","year":"2019","unstructured":"Liu N, Xu Z (2019) Using LeDock as a docking tool for computational drug design. IOP Conf Ser Earth Environ Sci 218(1):012143. https:\/\/doi.org\/10.1088\/1755-1315\/218\/1\/012143","journal-title":"IOP Conf Ser Earth Environ Sci"},{"issue":"15","key":"11556_CR50","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/jcc.23905","volume":"36","author":"WJ Allen","year":"2015","unstructured":"Allen WJ, Balius TE, Mukherjee S, Brozell SR, Moustakas DT, Lang PT, Case DA, Kuntz ID, Rizzo RC (2015) DOCK 6: Impact of new features and current docking performance. J Comput Chem 36(15):1132\u20131156. https:\/\/doi.org\/10.1002\/jcc.23905","journal-title":"J Comput Chem"},{"issue":"7","key":"11556_CR51","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1021\/acs.jcim.3c00253","volume":"64","author":"X Zhang","year":"2024","unstructured":"Zhang X, Gao H, Wang H, Chen Z, Zhang Z, Chen X, Li Y, Qi Y, Wang R (2024) PLANET: A multi-objective graph neural network model for protein-ligand binding affinity prediction. J Chem Inf Model 64(7):2205\u20132220. https:\/\/doi.org\/10.1021\/acs.jcim.3c00253","journal-title":"J Chem Inf Model"},{"issue":"9","key":"11556_CR52","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s43588-023-00511-5","volume":"3","author":"X Zhang","year":"2023","unstructured":"Zhang X, Zhang O, Shen C, Qu W, Chen S, Cao H, Kang Y, Wang Z, Wang E, Zhang J, Deng Y, Liu F, Wang T, Du H, Wang L, Pan P, Chen G, Hsieh CY, Hou T (2023) Efficient and accurate large library ligand docking with KarmaDock. Nat Comput Sci 3(9):789\u2013804. https:\/\/doi.org\/10.1038\/s43588-023-00511-5","journal-title":"Nat Comput Sci"},{"key":"11556_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O'Boyle","year":"2011","unstructured":"O\u2019Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR (2011) Open Babel: an open chemical toolbox. J Cheminform 3:33. https:\/\/doi.org\/10.1186\/1758-2946-3-33","journal-title":"J Cheminform"},{"issue":"W1","key":"11556_CR54","doi-asserted-by":"publisher","first-page":"W422","DOI":"10.1093\/nar\/gkae236","volume":"52","author":"L Fu","year":"2024","unstructured":"Fu L, Shi S, Yi J, Wang N, He Y, Wu Z, Peng J, Deng Y, Wang W, Wu C, Lyu A, Zeng X, Zhao W, Hou T, Cao D (2024) ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support. Nucleic Acids Res 52(W1):W422-w431. https:\/\/doi.org\/10.1093\/nar\/gkae236","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"11556_CR55","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina A, Michielin O, Zoete V (2019) SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res 47(W1):W357-w364. https:\/\/doi.org\/10.1093\/nar\/gkz382","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"11556_CR56","doi-asserted-by":"publisher","first-page":"W489","DOI":"10.1093\/nar\/gkae380","volume":"52","author":"Z Li","year":"2024","unstructured":"Li Z, Qu N, Zhou J, Sun J, Ren Q, Meng J, Wang G, Wang R, Liu J, Chen Y, Zhang S, Zheng M, Li X (2024) KinomeMETA: a web platform for kinome-wide polypharmacology profiling with meta-learning. Nucleic Acids Res 52(W1):W489-w497. https:\/\/doi.org\/10.1093\/nar\/gkae380","journal-title":"Nucleic Acids Res"},{"key":"11556_CR57","doi-asserted-by":"publisher","first-page":"1.30.1","DOI":"10.1002\/cpbi.5","volume":"54","author":"G Stelzer","year":"2016","unstructured":"Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, Stein TI, Nudel R, Lieder I, Mazor Y, Kaplan S, Dahary D, Warshawsky D, Guan-Golan Y, Kohn A, Rappaport N, Safran M, Lancet D (2016) The GeneCards Suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics 54:1.30.1-1.30.33. https:\/\/doi.org\/10.1002\/cpbi.5","journal-title":"Curr Protoc Bioinformatics"},{"issue":"1","key":"11556_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK (2019) Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 10(1):1523. https:\/\/doi.org\/10.1038\/s41467-019-09234-6","journal-title":"Nat Commun"},{"issue":"12","key":"11556_CR59","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/s0969-2126(02)00907-3","volume":"10","author":"J Nowakowski","year":"2002","unstructured":"Nowakowski J, Cronin CN, McRee DE, Knuth MW, Nelson CG, Pavletich NP, Rogers J, Sang BC, Scheibe DN, Swanson RV, Thompson DA (2002) Structures of the cancer-related Aurora-A, FAK, and EphA2 protein kinases from nanovolume crystallography. Structure 10(12):1659\u20131667. https:\/\/doi.org\/10.1016\/s0969-2126(02)00907-3","journal-title":"Structure"},{"issue":"1","key":"11556_CR60","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1124\/pr.114.009381","volume":"67","author":"RS Knipe","year":"2015","unstructured":"Knipe RS, Tager AM, Liao JK (2015) The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis. Pharmacol Rev 67(1):103\u2013117. https:\/\/doi.org\/10.1124\/pr.114.009381","journal-title":"Pharmacol Rev"},{"key":"11556_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126211","author":"P Montero","year":"2021","unstructured":"Montero P, Milara J, Roger I, Cortijo J (2021) Role of JAK\/STAT in interstitial lung diseases; molecular and cellular mechanisms. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22126211","journal-title":"Int J Mol Sci"},{"key":"11556_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155122","volume":"254","author":"S Saleem","year":"2024","unstructured":"Saleem S (2024) Targeting MAPK signaling: a promising approach for treating inflammatory lung disease. Pathol Res Pract 254:155122. https:\/\/doi.org\/10.1016\/j.prp.2024.155122","journal-title":"Pathol Res Pract"},{"issue":"3","key":"11556_CR63","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/s1875-5364(21)60116-4","volume":"20","author":"YD Zhao","year":"2022","unstructured":"Zhao YD, Zhang X, Yang WY, Zhang RQ, Mu LT, Han L, Lv CN, Lu JC (2022) New anti-pulmonary fibrosis prenylflavonoid glycosides from Epimedium koreanum. Chin J Nat Med 20(3):221\u2013228. https:\/\/doi.org\/10.1016\/s1875-5364(21)60116-4","journal-title":"Chin J Nat Med"},{"issue":"19","key":"11556_CR64","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1080\/14786419.2023.2246631","volume":"38","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Teng L, Zhang R, Lv C, Lu J (2024) Two new prenylated flavonol glycosides from Epimedium koreanum Nakai leaves and their anti-pulmonary fibrosis activities. Nat Prod Res 38(19):3336\u20133343. https:\/\/doi.org\/10.1080\/14786419.2023.2246631","journal-title":"Nat Prod Res"},{"key":"11556_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1619581","volume":"16","author":"J Zhao","year":"2025","unstructured":"Zhao J, Zhang W (2025) Icariin and related metabolites in fibrosis management: pharmacological properties and molecular mechanism. Front Pharmacol 16:1619581. https:\/\/doi.org\/10.3389\/fphar.2025.1619581","journal-title":"Front Pharmacol"},{"key":"11556_CR66","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.2147\/dddt.S243420","volume":"14","author":"Y Liao","year":"2020","unstructured":"Liao Y, Tan RZ, Li JC, Liu TT, Zhong X, Yan Y, Yang JK, Lin X, Fan JM, Wang L (2020) Isoliquiritigenin attenuates UUO-induced renal inflammation and fibrosis by inhibiting Mincle\/Syk\/NF-Kappa B signaling pathway. Drug Des Devel Ther 14:1455\u20131468. https:\/\/doi.org\/10.2147\/dddt.S243420","journal-title":"Drug Des Devel Ther"},{"key":"11556_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2024.109808","volume":"136","author":"R Liu","year":"2025","unstructured":"Liu R, Zhang Y, Liu M, Shang Z, Song S, Zhang Y, Zhou Y, Tu C (2025) Natural molecule Isoliquiritigenin mitigates MASH and liver fibrosis in mice by promoting autophagy through the PI3K\/Akt signaling pathway. J Nutr Biochem 136:109808. https:\/\/doi.org\/10.1016\/j.jnutbio.2024.109808","journal-title":"J Nutr Biochem"},{"issue":"29","key":"11556_CR68","doi-asserted-by":"publisher","first-page":"18252","DOI":"10.1021\/acs.jafc.5c01904","volume":"73","author":"X Mei","year":"2025","unstructured":"Mei X, Zhang Q, Shao W, Zheng J, Zhao P, Li J (2025) Targeted inhibition of aldose reductase by Isoliquiritigenin suppresses fatty acid synthesis to inhibit macrophage M2 polarization and alleviate pulmonary fibrosis. J Agric Food Chem 73(29):18252\u201318267. https:\/\/doi.org\/10.1021\/acs.jafc.5c01904","journal-title":"J Agric Food Chem"},{"key":"11556_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154587","volume":"112","author":"M Guo","year":"2023","unstructured":"Guo M, Wang Z, Dai J, Fan H, Yuan N, Gao L, Peng H, Cheng X (2023) Glycyrrhizic acid alleviates liver fibrosis in vitro and in vivo via activating CUGBP1-mediated IFN-\u03b3\/STAT1\/Smad7 pathway. Phytomedicine 112:154587. https:\/\/doi.org\/10.1016\/j.phymed.2022.154587","journal-title":"Phytomedicine"},{"key":"11556_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00215","volume":"6","author":"L Gao","year":"2015","unstructured":"Gao L, Tang H, He H, Liu J, Mao J, Ji H, Lin H, Wu T (2015) Glycyrrhizic acid alleviates bleomycin-induced pulmonary fibrosis in rats. Front Pharmacol 6:215. https:\/\/doi.org\/10.3389\/fphar.2015.00215","journal-title":"Front Pharmacol"},{"key":"11556_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.138207","volume":"286","author":"P Niu","year":"2025","unstructured":"Niu P, Zhang X, Zhang G, Jing R, Qiao Y, Zhou X, Bai M, Peng L (2025) A polysaccharide from Glycyrrhiza uralensis attenuates myocardial fibrosis via modulating the MAPK\/PI3K\/AKT signaling pathway. Int J Biol Macromol 286:138207. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.138207","journal-title":"Int J Biol Macromol"},{"key":"11556_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119940","volume":"349","author":"H Ren","year":"2025","unstructured":"Ren H, Zhao C, Zhou L, Ke Q, Chen Y, Chen Z, He J, Chen D, He X, Quan M, Liu L, Li R, Pan H (2025) Licochalcone B attenuates pulmonary fibrosis via inhibiting ZBP1-dependent PANoptosis. J Ethnopharmacol 349:119940. https:\/\/doi.org\/10.1016\/j.jep.2025.119940","journal-title":"J Ethnopharmacol"},{"issue":"11","key":"11556_CR73","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1002\/ptr.6171","volume":"32","author":"L Abenavoli","year":"2018","unstructured":"Abenavoli L, Izzo AA, Mili\u0107 N, Cicala C, Santini A, Capasso R (2018) Milk thistle (Silybum marianum): a concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases. Phytother Res 32(11):2202\u20132213. https:\/\/doi.org\/10.1002\/ptr.6171","journal-title":"Phytother Res"},{"issue":"12","key":"11556_CR74","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.22038\/ijbms.2019.14069","volume":"22","author":"RF Ahmed","year":"2019","unstructured":"Ahmed RF, Moussa RA, Eldemerdash RS, Zakaria MM, Abdel-Gaber SA (2019) Ameliorative effects of silymarin on HCl-induced acute lung injury in rats; role of the Nrf-2\/HO-1 pathway. Iran J Basic Med Sci 22(12):1483\u20131492. https:\/\/doi.org\/10.22038\/ijbms.2019.14069","journal-title":"Iran J Basic Med Sci"},{"key":"11556_CR75","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7283104","volume":"2019","author":"ZJ Liu","year":"2019","unstructured":"Liu ZJ, Zhong J, Zhang M, Chen ZH, Wang JY, Chen HY, Wang XQ, Zhang B (2019) The alexipharmic mechanisms of five licorice ingredients involved in CYP450 and Nrf2 pathways in paraquat-induced mice acute lung injury. Oxid Med Cell Longev 2019:7283104. https:\/\/doi.org\/10.1155\/2019\/7283104","journal-title":"Oxid Med Cell Longev"},{"issue":"9","key":"11556_CR76","doi-asserted-by":"publisher","first-page":"5290","DOI":"10.1002\/ptr.7210","volume":"35","author":"SA Ali","year":"2021","unstructured":"Ali SA, Saifi MA, Godugu C, Talla V (2021) Silibinin alleviates silica-induced pulmonary fibrosis: potential role in modulating inflammation and epithelial-mesenchymal transition. Phytother Res 35(9):5290\u20135304. https:\/\/doi.org\/10.1002\/ptr.7210","journal-title":"Phytother Res"},{"key":"11556_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/jof8101010","author":"VQ Resende","year":"2022","unstructured":"Resende VQ, Reis-Goes KH, Finato AC, de F\u00e1tima Almeida-Donanzam D, Dos Santos AR, Perico J, Amorim BC, Venturini J (2022) Combined silymarin and cotrimoxazole therapy attenuates pulmonary fibrosis in experimental paracoccidioidomycosis. J Fungi. https:\/\/doi.org\/10.3390\/jof8101010","journal-title":"J Fungi"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11556-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11556-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11556-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:02:47Z","timestamp":1791165767000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11556-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,26]]},"references-count":77,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["11556"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11556-9","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,26]]},"assertion":[{"value":"29 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}